VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_14-vv-00467 Package ID: USCOURTS-cofc-1_14-vv-00467 Petitioner: Jeanna Terrell Filed: 2014-12-04 Decided: 2015-01-06 Vaccine: Tdap Vaccination date: 2012-05-22 Condition: erythema multiforme and pemphigus vulgaris Outcome: compensated Award amount USD: 6377 AI-assisted case summary: Jeanna Terrell, born June 13, 1968, filed a petition on December 4, 2014, alleging that a Tdap vaccine administered on May 22, 2012, caused her to suffer from erythema multiforme and pemphigus vulgaris. Petitioner had a history of rashes predating the vaccination. Following the vaccination, in June 2012, she developed a blistery rash and experienced abdominal pain and nausea, for which she was treated with a steroid dose pack. Medical records from July 2012 initially suggested that pemphigus vulgaris might have been triggered by the vaccine. However, a biopsy performed on July 23, 2013, and analyzed by Dr. Raminder K. Grover, found that petitioner's skin condition was not consistent with pemphigus, pemphigoid, or related conditions, ruling out these diagnoses in approximately 90% of cases. Despite this, on July 30, 2013, petitioner's treating dermatologist, Dr. Susannah McClain, informed petitioner and noted in her medical records that the biopsy result was consistent with pemphigus vulgaris, suggesting the pertussis vaccine may have triggered it, citing reports of influenza and tetanus/diphtheria vaccines triggering pemphigus. Petitioner's counsel, Edward M. Kraus, stated during a telephonic status conference on November 4, 2014, that Dr. McClain had since informed his client that she did not have pemphigus vulgaris, and therefore, there was no reasonable basis to proceed. Petitioner subsequently filed a motion to dismiss her petition, stating she would be unable to prove entitlement to compensation. Special Master Laura D. Millman granted the motion and dismissed the case on November 12, 2014, for failure to prove the allegations by a preponderance of the evidence, noting that petitioner had not filed a medical expert report to support her claim and that the medical records did not prove she had pemphigus vulgaris. The respondent was represented by Heather L. Pearlman. On January 6, 2015, Special Master Millman issued a decision awarding $6,377.18 in attorneys' fees and costs based on a stipulation between the parties, payable jointly to petitioner and the Law Offices of Chicago-Kent College of Law. Theory of causation field: Petitioner Jeanna Terrell, age 43.95, received a Tdap vaccine on May 22, 2012. She alleged this vaccine caused erythema multiforme and pemphigus vulgaris. Petitioner had a history of rashes prior to vaccination. Weeks after vaccination, she developed a blistery rash and abdominal pain. Initial medical records suggested a possible vaccine trigger for pemphigus vulgaris. However, a biopsy on July 23, 2013, analyzed by Dr. Raminder K. Grover, found the condition inconsistent with pemphigus, pemphigoid, or related conditions. Petitioner's treating dermatologist, Dr. Susannah McClain, initially stated the biopsy was consistent with pemphigus vulgaris and suggested a vaccine trigger, but later advised petitioner she did not have this diagnosis. Petitioner did not file a medical expert report. The Special Master, Laura D. Millman, dismissed the case on November 12, 2014, for failure to prove causation by a preponderance of the evidence, as the medical records did not confirm the diagnosis and no expert support was provided. The case was dismissed on the merits. Subsequently, on January 6, 2015, a stipulation led to an award of $6,377.18 for attorneys' fees and costs. Petitioner's counsel was Edward M. Kraus, and respondent's counsel was Heather L. Pearlman. The theory of causation was off-Table. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_14-vv-00467-0 Date issued/filed: 2014-12-04 Pages: 5 Docket text: PUBLIC DECISION (Originally filed: 11/12/2014) regarding 15 DECISION of Special Master Signed by Special Master Laura D Millman. (tlj) Copy to parties. -------------------------------------------------------------------------------- Case 1:14-vv-00467-UNJ Document 19 Filed 12/04/14 Page 1 of 5 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 14-467V November 12, 2014 Not to be Published *************************************** JEANNA TERRELL, * * Petitioner, * Tetanus vaccine; alleged reaction not * consistent with pemphigus vulgaris; v. * petitioner’s motion for decision dismissing * her petition SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * *************************************** Edward M. Kraus, Chicago, IL, for petitioner. Heather L. Pearlman, Washington, DC, for respondent. MILLMAN, Special Master DECISION1 On June 3, 2014, petitioner filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. §§ 300aa-10–34 (2006), alleging that tetanus-diphtheria-acellular pertussis (“Tdap”) vaccine administered on May 22, 2012, caused her to suffer from erythema multiforme and pemphigus vulgaris. 1 Because this decision contains a reasoned explanation for the special master’s action in this case, the special master intends to post this decision on the United States Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made available to the public unless they contain trade secrets or commercial or financial information that is privileged and confidential, or medical or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is filed, petitioners have 14 days to identify and move to redact such information prior to the document’s disclosure. If the special master, upon review, agrees that the identified material fits within the categories listed above, the special master shall redact such material from public access. Case 1:14-vv-00467-UNJ Document 19 Filed 12/04/14 Page 2 of 5 Although earlier filed medical records stated petitioner had pemphigus vulgaris that her vaccination may have triggered, a later filed biopsy showed that petitioner did not have a skin condition consistent with pemphigus, pemphigoid, or any related conditions. On November 4, 2014, the undersigned held a telephonic status conference with counsel. During the conference, petitioner’s attorney said he would file a motion to dismiss because petitioner’s treating dermatologist Dr. McClain said petitioner never had pemphigus vulgaris. Petitioner’s counsel said there was no longer a reasonable basis to proceed. On November 7, 2014, petitioner filed Petitioner’s Motion for a Decision Dismissing her Petition. She states “that at this time she will be unable to prove that she is entitled to compensation in the Vaccine Program.” Mot. at ¶ 1. She also states that “[i]n these circumstances, to proceed further would be unreasonable.” Id. at ¶ 2. The undersigned GRANTS petitioner’s motion and DISMISSES this case for failure to prove the allegations in her petition by a preponderance of the evidence. 42 U.S.C. § 300aa- 13(a)(1)(A). FACTS Petitioner was born on June 13, 1968. Petitioner has a history of rashes dating even before her Tdap vaccination at issue. On January 22, 2009, she complained of a rash on her upper thigh that had been there for six weeks. Med. recs. Ex. 5, at 2. This rash spread to her abdomen. Id. She had several lesions on her abdomen and left leg. Id. On May 22, 2012, petitioner received Tdap vaccine. Med. recs. Ex. 6, at 1. On July 25, 2012, petitioner went to a doctor, complaining of a blistery rash all over her body in June for three weeks. Med. recs. Ex. 5, at 7. She also had abdominal pain and nausea. Id. She was treated with a steroid dose pack. Id. A note dated July 23, 2012 states petitioner had an allergic reaction to Cipro after a prior allergic reaction to Benadryl. Med. recs. Ex. 14, at 3. On August 29, 2012, petitioner saw Dr. Sean J. Murphy, who diagnosed her with actinic keratosis. Med. recs. Ex. 4, at 4. On October 18, 2012, petitioner saw Dr. Alex G. Yip, an allergist, complaining of recurrent and persistent rashes over the prior few months and mild, seasonal rhinitis. Med. recs. Ex. 1, at 4. She had stomach issues in May with intermittent burning pain sensations, which were worse with eating. Id. She had long-term gastroesophageal reflux disease therapy, but the gastrointestinal issue resolved itself. Id. At about that time, she noted the onset of small red 2 Case 1:14-vv-00467-UNJ Document 19 Filed 12/04/14 Page 3 of 5 spots on her palms with intense itching. Id. This would wax and wane without clear triggers. Id. In June, she developed a diffuse fine, papular/blister-like rash over her back that she attributed to sun poisoning, but the rash spread to non-exposed areas. Id. On July 23, 2013, petitioner saw Dr. Susannah McClain, who diagnosed her with unspecified dermatosis. Med. recs. Ex. 3, at 3. Also on July 23, 2013, a biopsy was done. Med. recs. Ex. 13, at 2. Dr. Raminder K. Grover analyzed the biopsy, finding that petitioner’s skin condition was not consistent with pemphigus, pemphigoid, or any related conditions. Id. These biopsy findings ruled out pemphigus, bullous pemphigoid (BP), other pemphigoid forms, linear IgA bullous dermatosis (LABD), and epidermolysis bullosa acquisita (EBA) in about 90% of cases. Id. On July 30, 2013, for an unknown reason, Dr. McClain told petitioner and wrote in her medical notes that petitioner’s biopsy result was consistent with pemphigus vulgaris. Med. recs. Ex. 3, at 10. Dr. McClain wrote that pertussis vaccine may have triggered this condition, as reports exist of influenza and tetanus/diphtheria vaccines triggering pemphigus. Id. During a telephonic status conference held on July 10, 2014, respondent requested that petitioner file the July 23, 2013 biopsy report. In an Order dated July 10, 2014, the undersigned ordered petitioner to file the biopsy report and other material. Petitioner filed the biopsy report on August 25, 2014. Med. recs. Ex. 13. On September 8, 2014, the undersigned held a telephonic status conference with counsel during which petitioner’s counsel stated he was surprised at the results of the report. He wanted to obtain clarification from Dr. McClain, petitioner’s treating dermatologist. In an Order dated September 8, 2014, the undersigned ordered petitioner to file a status report by October 8, 2014 indicating how she intended to proceed after consultation with her dermatologist. On October 8, 2014, petitioner filed a status report stating that she had an appointment with Dr. McClain on October 28, 2014. On November 4, 2014, the undersigned held a telephonic status conference with counsel during which petitioner’s counsel said that Dr. McClain told his client she did not have pemphigus vulgaris. Counsel said he would file a motion to dismiss because there was no reasonable basis to proceed. DISCUSSION To satisfy her burden of proving causation in fact, petitioner must prove by preponderant evidence: “(1) a medical theory causally connecting the vaccination and the injury; (2) a logical sequence of cause and effect showing that the vaccination was the reason for the injury; and (3) a 3 Case 1:14-vv-00467-UNJ Document 19 Filed 12/04/14 Page 4 of 5 showing of a proximate temporal relationship between vaccination and injury.” Althen v. Sec’y of HHS, 418 F.3d 1274, 1278 (Fed. Cir. 2005). In Althen, the Federal Circuit quoted its opinion in Grant v. Secretary of Health and Human Services, 956 F.2d 1144, 1148 (Fed. Cir. 1992): A persuasive medical theory is demonstrated by “proof of a logical sequence of cause and effect showing that the vaccination was the reason for the injury[,]” the logical sequence being supported by “reputable medical or scientific explanation[,]” i.e., “evidence in the form of scientific studies or expert medical testimony[.]” Althen, 418 F.3d at 1278. Without more, “evidence showing an absence of other causes does not meet petitioners’ affirmative duty to show actual or legal causation.” Grant, 956 F.2d at 1149. Mere temporal association is not sufficient to prove causation in fact. Id. at 1148. Petitioner must show not only that but for Tdap vaccination, she would not have whatever reaction she thinks she had, but also that the vaccine was a substantial factor in causing her condition and, but for the vaccination, she would not have had whatever reaction she thinks she had. Shyface v. Sec’y of HHS, 165 F.3d 1344, 1352 (Fed. Cir. 1999). Although petitioner alleges that Tdap vaccination caused her pemphigus vulgaris, the medical records do not prove she has pemphigus vulgaris. Petitioner did not file a medical expert report in support of her allegation. The Vaccine Act does not permit the undersigned to rule for petitioner based on her claims alone, “unsubstantiated by medical records or by medical opinion.” 42 U.S.C. § 300aa-13(a)(1) (2006). Thus, petitioner has not made a prima facie case of causation. The undersigned GRANTS petitioner’s motion and DISMISSES this case for petitioner’s failure to prove the allegations in her petition by a preponderance of the evidence. 42 U.S.C. § 300aa-13(a)(1)(A). CONCLUSION This petition is DISMISSED. In the absence of a motion for review filed pursuant to RCFC, Appendix B, the clerk of the court is directed to enter judgment herewith.2 2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or jointly, filing a notice renouncing the right to seek review. 4 Case 1:14-vv-00467-UNJ Document 19 Filed 12/04/14 Page 5 of 5 IT IS SO ORDERED. November 12, 2014 /s/ Laura D. Millman DATE Laura D. Millman Special Master 5 ================================================================================ DOCUMENT 2: USCOURTS-cofc-1_14-vv-00467-1 Date issued/filed: 2015-01-27 Pages: 2 Docket text: PUBLIC DECISION (Originally filed: 01/06/2015) regarding 21 DECISION Fees Stipulation/Proffer Signed by Special Master Laura D Millman. (tlj) Copy to parties. -------------------------------------------------------------------------------- Case 1:14-vv-00467-UNJ Document 22 Filed 01/27/15 Page 1 of 2 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 14-467V Filed: January 6, 2015 Not for Publication ************************************* JEANNA TERRELL, * * Petitioner, * Attorneys’ fees and costs decision based on * stipulation of facts v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * ************************************* Edward M. Kraus, Chicago, IL, for petitioner. Heather L. Pearlman, Washington, DC, for respondent. MILLMAN, Special Master DECISION AWARDING ATTORNEYS’ FEES AND COSTS1 On January 5, 2015, the parties filed a stipulation of facts in which they agreed on an appropriate amount for attorneys’ fees and costs in this case. In accordance with the General Order #9 requirement, petitioner asserts that she did not incur any costs in pursuit of her petition. Petitioner submitted a draft application for attorneys’ fees and costs to respondent, requesting $6,377.18 in attorneys’ fees and costs. Respondent has reviewed the draft fee application and does not object to this amount. The undersigned finds this 1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this case, the special master intends to post this unpublished decision on the United States Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, 116 Stat. 2899, 2913 (Dec. 17, 2002). Vaccine Rule 18(b) states that all decisions of the special masters will be made available to the public unless they contain trade secrets or commercial or financial information that is privileged and confidential, or medical or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and move to redact such information prior to the document=s disclosure. If the special master, upon review, agrees that the identified material fits within the banned categories listed above, the special master shall redact such material from public access. Case 1:14-vv-00467-UNJ Document 22 Filed 01/27/15 Page 2 of 2 amount to be reasonable. Accordingly, the court awards $6,377.18, representing reimbursement for attorneys’ fees and costs. The award shall be in the form of a check payable jointly to petitioner and the Law Offices of Chicago-Kent College of Law in the amount of $6,377.18. In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment herewith.2 IT IS SO ORDERED. Dated: January 6, 2015 s/ Laura D. Millman Laura D. Millman Special Master 2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party, either separately or jointly, filing a notice renouncing the right to seek review. 2